Frank Verwiel
Vermogen: 649 414 $ op 31-05-2026
Vermogen: 649 414 $ op 31-05-2026
Frank A. G. M. Verwiel is een Nederlandse zakenman die aan het roer heeft gestaan van 6 verschillende bedrijven. Hij is voorzitter van ObsEva SA, voorzitter van Intellia Therapeutics, Inc. en voorzitter van Aptalis Pharma US, Inc. Hij zit ook in de raad van bestuur van Bavarian Nordic An en Bavarian Nordic GmbH. In zijn vorige loopbaan was Frank A. G. M. Verwiel VP-Hypertension & Worldwide Human Health Marketing bij Merck & Co, Inc., President, Chief Executive Officer & Bestuurder bij Aptalis Pharma, Inc., President & Chief Executive Officer van Aptalis Pharma SAS, President, Chief Executive Officer & Bestuurder bij Aptalis Holdings, Inc. en Bestuurder & Bestuurder van de Sectie Gezondheidszorg bij Biotechnology Innovation Organization. Frank A. G. M. Verwiel behaalde een MBA aan INSEAD en een doctoraat aan de Erasmus Universiteit Rotterdam.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-06-2026 | 35.148 ( 0,03% ) | 494 532 $ | 31-05-2026 | |
BAVARIAN NORDIC A/S 0,01% | 31-12-2025 | 5.293 ( 0,01% ) | 154 882 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BAVARIAN NORDIC A/S | Directeur/Bestuurslid | 20-04-2016 |
| INTELLIA THERAPEUTICS, INC. | Voorzitter | 01-02-2020 |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | President | - |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Directeur/Bestuurslid | 01-01-2016 |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Directeur/Bestuurslid | 01-08-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| OBSEVA SA | Voorzitter | 18-05-2022 |
| ACHILLION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 28-01-2020 |
| AVEXIS INC | Directeur/Bestuurslid | 01-06-2018 |
| INTERMUNE INC | Directeur/Bestuurslid | 01-09-2014 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 16 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology | Health Technology |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Health Technology |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erasmus University Rotterdam
Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TA SASU
TA SASU Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on gastrointestinal diseases and cystic fibrosis | Health Technology |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Health Technology |
Aptalis Holdings, Inc.
Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operating as a holding company that develops, manufactures, licenses, markets and distributes therapies | Health Technology |
ObsEva SA
ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau